UiPath, Inc. (PATH) stock
PATHNYSEServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 14/304% above fair value
$13.14+0.31 (+2.42%)
Close on Nov 11, 2026Market cap $6.85BP/E 19.6Yield –
UiPath EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
UiPath's EPS for the twelve months ending Jul 31, 2026 was $0.67, up 2133.3% year over year. For fiscal 2026 it was $0.52. The highest annual figure on record is $0.52 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $0.52 | – |
| FY2025 | Jan 31, 2025 | -$0.13 | – |
| FY2024 | Jan 31, 2024 | -$0.16 | – |
| FY2023 | Jan 31, 2023 | -$0.60 | – |
| FY2022 | Jan 31, 2022 | -$1.16 | – |
| FY2021 | Jan 31, 2021 | -$0.55 | – |
| FY2020 | Jan 31, 2020 | -$3.41 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $0.07 | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $0.04 | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $0.19 | +111.1% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $0.37 | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $0.00 | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$0.04 | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $0.09 | +50.0% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$0.02 | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$0.15 | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$0.05 | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $0.06 | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$0.06 | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$0.11 | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$0.06 | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$0.05 | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$0.10 | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$0.22 | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$0.23 | -253.3% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$0.23 | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$0.19 | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$1.11 | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $0.15 | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$0.41 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $0.00 | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$0.33 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?